- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02960932
Reproducibility Inter-session of the Measurement Elastography of the Passive Stiffness of Medial Beams of Gastrocnemius Muscle of the Hemiplegic Cerebral Child. (ELASTOREPRO)
September 13, 2017 updated by: Centre Hospitalier Universitaire de Saint Etienne
Muscles, paretics and spastics, of cerebral palsy children have very early, for growth (three at five aged), every alteration of theirs properties.
Gastrocnemius muscle, often reaches on the cerebral palsy, characterised by a modification of the structure (volume decrease) and the elasticity (increase of the passive stiffness).
Every alterations of the muscular property have impact clinic and functional important.
The many treatments of orthopaedic targeting (lengthening of cast, injections of botulinic toxin), repeated to a multiple recovery during the growth influences the muscular characteristics.
There is a real interest to measure the muscular property development during children's growth.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Elastography is a technical assessment of characteristic of the soft tissues.
In this area, the method " Supersonic Shear Imaging® (SSI) " provide an important technological change measuring, swiftly and no invasive, a elasticity modulus reflecting the property visco-elastic of the muscle.
A lot of ex vivo study led in isolated muscle and in vivo in healthy adults demonstrated the validity of the method SSI on the evaluation of the passive stiffness from a number of muscle group whose the gastrocnemius muscle.
The main objective of this study must be checked the intersession reproducibility of the method SSI on the evaluation of the passive stiffness at the medial bundle of the gastrocnemius muscle therefore their passive lengthening in cerebral palsy children.
The secondary objective is to test the correlation level of the relation elasticity modulus/ joint angle and couple force-angle obtained throughout the passive lengthening at the medial bundle of the gastrocnemius muscle in cerebral palsy children.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint Etienne, France, 42055
- Chu de Saint Etienne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parents affiliated or entitled to a social security;
- Children diagnosed spastic cerebral paralyzed, with a clinical picture of hemiplegia infantile cerebral;
- Children walking GMFCS (Gross Motor Functional Classification System) between I and III;
- Children with spasticity level in the paralysing gastrocnemius muscle greater than or equal X1, VII, on the scale of Tardieu and 2 on the Ashworth scale.
- Children aged 5 to 12 years.
- Children can understand and follow the simple instructions in the examination process.
- Consent signed by the holder of parental authority.
Exclusion Criteria:
- Children with concomitant muscle disease (myopathy ...).
- Children who received another treatment to target relaxant (baclofen, ... muscle relaxant) which would have begun in the months preceding the assessment.
- Children who underwent neuro-orthopedic surgery at the where paretic members.
- Children who received an injection of botulinic toxin for less than 15 days.
- Children who have benefited from extensions casts for less than 7 days.
- Children who received a therapeutic target for orthopedic (botulinum toxin, plaster of extensions, installation of equipment of lower limb) between the two sessions evaluations.
- Children who received a physiotherapy session the day before evaluation elastography and ultrasound.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: hemiplegic cerebral child
Ultrasound scanner used to the SSI technical reproducibility.
|
Ultrasound scanner used to the SSI technical reproducibility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of elasticity modulus
Time Frame: 7 days
|
To measure at the medial bundle of the gastrocnemius muscle at the passive mobilization of the ankle in the joint sector following: 30 degree in plantar and maximal dorsal flexion; calculation of yield curve of elasticity modulus, joint angle in kilopascals (kPa).
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of force couple
Time Frame: 7 days
|
Stored measure at the passive mobilization of the ankle in position of maximal dorsal flexion; calculation of yield couple of joint force-angle in nanometer.
|
7 days
|
|
Measure of fascicular length
Time Frame: 7 days
|
To measure at the medial bundle of the gastrocnemius muscle at the passive mobilization of the ankle in the selected joint sector (30 degree in plantar and maximal dorsal flexion); calculation of the difference of fascicular length in millimeter between the extreme position of joint sector: 30 degree in plantar and maximal dorsal flexion.
|
7 days
|
|
Measure of pennation angle of the muscular fascicle
Time Frame: 7 days
|
To measure at the medial bundle of the gastrocnemius muscle at the passive mobilization in the selected joint sector in degree; calculation of the difference of pennation angle of the muscular fascicle between the extreme position of joint sector: 30 degree in plantar and maximal dorsal flexion.
|
7 days
|
|
Measure of elasticity modulus
Time Frame: 7 days
|
Measure of elasticity modulus at the medial bundle of the gastrocnemius muscle in rest position kilopascals (kPa).
|
7 days
|
|
Measure of muscle stiffness
Time Frame: 7 days
|
Difference of muscle stiffness evaluated between the paretic and no paretic member.
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Vincent Gautheron, MD PhD, Centre Hospitalier Universitaire de Saint Etienne
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 21, 2017
Primary Completion (Actual)
March 10, 2017
Study Completion (Actual)
March 10, 2017
Study Registration Dates
First Submitted
November 8, 2016
First Submitted That Met QC Criteria
November 8, 2016
First Posted (Estimate)
November 10, 2016
Study Record Updates
Last Update Posted (Actual)
September 14, 2017
Last Update Submitted That Met QC Criteria
September 13, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1608112
- 2016-A01558-43 (Other Identifier: ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gait
-
Centre Mutualiste de Rééducation et de Réadaptation...CompletedHealthy Volunteers | Gait | Child Development | Normal Gait | Normal Gait in Children | Pediatric Normative Gait DataFrance
-
Northumbria UniversityDANU Sports LtdRecruitingGait | Running | Walking | Gait AnalysisUnited Kingdom
-
Charles LinJewish Healthcare FoundationTerminated
-
Istanbul University - CerrahpasaCompletedGait Analysis | 3D Gait AnalysisTurkey
-
Peking University Third HospitalNot yet recruiting
-
University Hospital, GhentUniversity GhentRecruiting
-
University of NebraskaWithdrawn
-
University of PittsburghNational Institute on Aging (NIA)Completed
-
Gdansk University of Physical Education and SportNot yet recruiting
Clinical Trials on ultrasound scanner
-
Washington University School of MedicineCompleted
-
QT Ultrasound LLCAnalysis Group, Inc.SuspendedBreast Cancer ScreeningUnited States
-
Mayo ClinicUnited States Department of DefenseRecruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Cancer Institute (NCI); University of California, San Diego; GE Healthcare and other collaboratorsCompletedHepatocellular Carcinoma | Chemoembolization, TherapeuticUnited States
-
RWTH Aachen UniversityUnknownAngina Pectoris | Left Ventricular Wall Motion AbnormalitiesGermany
-
Northwestern UniversitySiemens Medical SolutionsCompletedBreast DiseasesUnited States
-
Mayo ClinicCompletedIntrauterine Growth Restriction | IUGR | VillitisUnited States
-
Mayo ClinicCompletedBreast CarcinomaUnited States
-
Calvary Hospital, Bronx, NYUnknown